Search

Your search keyword '"Real, Francisco X."' showing total 74 results

Search Constraints

Start Over You searched for: Author "Real, Francisco X." Remove constraint Author: "Real, Francisco X." Database OAIster Remove constraint Database: OAIster
74 results on '"Real, Francisco X."'

Search Results

1. GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery

2. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization

Catalog

Books, media, physical & digital resources

3. Vitamin D effects on human colon normal and tumour organoids

4. Vitamin D effects on human colon normal and tumour organoids

5. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

6. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

7. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

8. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

9. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

10. Immunohistochemistry-based taxonomical classification of Bladder cancer predicts response to neoadjuvant chemotherapy

11. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice

12. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice

13. Loss of GATA4 causes ectopic pancreas in the stomach

14. Loss of GATA4 causes ectopic pancreas in the stomach

15. Loss of GATA4 causes ectopic pancreas in the stomach

16. Loss of GATA4 causes ectopic pancreas in the stomach

17. The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver

18. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer

19. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

20. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

21. Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups

22. European evidence-based guidelines on pancreatic cystic neoplasms

23. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

24. European evidence-based guidelines on pancreatic cystic neoplasms

25. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

26. European evidence-based guidelines on pancreatic cystic neoplasms

27. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

28. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

29. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

30. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

31. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

32. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

33. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

34. European evidence-based guidelines on pancreatic cystic neoplasms

35. European evidence-based guidelines on pancreatic cystic neoplasms

36. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

37. Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer : A Prospective Multicentre Validation Study

38. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

39. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study

40. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

41. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

42. CD49f labels an organoid-forming mouse urothelial cell population with stem cell features

43. Genome-wide association study identifies inversion in theCTRB1-CTRB2locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis

44. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

45. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

46. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.

47. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

48. Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

49. A urine based assay to select patients for initial cystoscopy

50. Characterization of Large Structural Genetic Mosaicism in Human Autosomes